Publications by authors named "Thomas Alessi"

Claim this Profile
A
A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs.
Doris Zane, Shane Roller, Josephine Shelton, Roshni Singh, Rachna Jain, Thomas Alessi

Microbiol Spectr· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes.
Robert R Henry, Julio Rosenstock, Douglas Logan, Thomas Alessi, Kenneth Luskey

J Diabetes Complications· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of continuous subcutaneous delivery of exenatide by ITCA 650 versus twice-daily exenatide injections in metformin-treated type 2 diabetes.
Robert R Henry, Julio Rosenstock, Douglas K Logan, Thomas R Alessi, Kenneth Luskey

Diabetes Care· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, open-label, multicenter, 4-week study to evaluate the tolerability and pharmacokinetics of ITCA 650 in patients with type 2 diabetes.
Robert R Henry, Douglas Logan, Thomas Alessi, Michelle A Baron

Clin Ther· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized study of antihypertensive efficacy and safety of combination aliskiren/valsartan vs valsartan monotherapy in hypertensive participants with type 2 diabetes mellitus.
George L Bakris, Suzanne Oparil, Das Purkayastha, Anthony M Yadao, Thomas Alessi

J Clin Hypertens (Greenwich)· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aliskiren alone or in combination with hydrochlorothiazide in Hispanic/Latino patients with systolic blood pressure 160 mm Hg to <180 mm Hg (Aliskiren Alone or in Combination with Hydrochlorothiazide in Patients with Stage 2 Hypertension to Provide Quick Intensive Control of Blood Pressure [ACQUIRE] substudy).
Henry R Black, Fernando Aguirre P, Melanie Wright, Thomas Alessi, Fabio Baschiera

J Clin Hypertens (Greenwich)· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of aliskiren/valsartan vs valsartan in nocturnal dipper and nondipper hypertensive patients: a pooled analysis.
Thomas D Giles, Thomas Alessi, Das Purkayastha, Dion Zappe

J Clin Hypertens (Greenwich)· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DUROS technology delivers peptides and proteins at consistent rate continuously for 3 to 12 months.
Catherine M Rohloff, Thomas R Alessi, Bing Yang, Janice Dahms, John P Carr

J Diabetes Sci Technol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis